Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 April 2009, doi:10.1136/bmj.b1756
Cite this as: BMJ 2009;338:b1756
Janice Hopkins Tanne
1 New York
| The first 150 words of the full text of this article appear below. |
The US Food and Drug Administration said on 22 April that it would accept and not appeal against a New York federal court decision that 17 year old women should be able to buy the emergency contraceptive pill Plan B without a prescription.
The agency said, "In accordance with the courts order, and consistent with the scientific findings made in 2005 by the [FDAs] Center for Drug Evaluation and Research, FDA notified the manufacturer of Plan B informing the company that it may, upon submission and approval of an appropriate application, market Plan B to women 17 years of age and older."
The case was originally brought in 2005 by the Center for Reproductive Rights, which sued the FDA for not giving over the counter status to Plan B, against advice from its own scientific experts. The court ruled on 23 March this year that the FDA should make the
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses